RECRUITING

Improving Infant Hydrocephalus Outcomes in Uganda

Description

Neonatal postinfectious hydrocephalus (PIH) is a major public health problem in East Africa.The standard treatment has long been placement of a ventriculoperitoneal shunt (VPS) but these devices require life-long maintenance and nearly all fail multiple times. Endoscopic Third Ventriculostomy (ETV) with Choroid Plexus Cauterization (ETV/CPC) is an alternate treatment to give patients a shunt-free life. In this study, the investigators aim to optimize the metrics of evaluation as quantitative prognostic indicators of treatment response and long term outcomes.

Conditions

Study Overview

Study Details

Study overview

Neonatal postinfectious hydrocephalus (PIH) is a major public health problem in East Africa.The standard treatment has long been placement of a ventriculoperitoneal shunt (VPS) but these devices require life-long maintenance and nearly all fail multiple times. Endoscopic Third Ventriculostomy (ETV) with Choroid Plexus Cauterization (ETV/CPC) is an alternate treatment to give patients a shunt-free life. In this study, the investigators aim to optimize the metrics of evaluation as quantitative prognostic indicators of treatment response and long term outcomes.

Improving Infant Hydrocephalus Outcomes in Uganda: Predicting Developmental Outcomes and Identifying Patients at Risk for Early Treatment Failure After ETV/CPC

Improving Infant Hydrocephalus Outcomes in Uganda

Condition
Hydrocephalus
Intervention / Treatment

-

Contacts and Locations

University Park

Penn State University, University Park, Pennsylvania, United States, 16802

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Infants less than 180 days (six months) old
  • * Symptomatic hydrocephalus characterized by abnormal rate of head growth, full anterior fontanel, ventriculomegaly
  • * A parent or a guardian qualified by Ugandan law to give informed consent
  • * Patients from Eastern, Central and Northern districts of Uganda, and in geographic proximity to CURE hospital will be eligible
  • * Age greater than six months
  • * No evidence of progressive hydrocephalus
  • * Patients outside of the districts specified in the inclusion criteria

Ages Eligible for Study

1 Day to 180 Days

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Boston Children's Hospital,

Pei-Yi Lin, PhD, PRINCIPAL_INVESTIGATOR, Boston Children's Hospital

Study Record Dates

2026-01